HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Pogledi
• 07/03/23
0
0
Ugraditi
administrator
Pretplatnici
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari